Author

B. J. Poelaert

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Research Focus:benchmarking· 1 Research Focus:database / resource· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Organism:virus· 1

Frequent Co-Authors

K. R. Brimacombe· 2 shared A. Friedman· 1 shared A. Patt· 1 shared A. Renn· 1 shared A. Simeonov· 1 shared A. V. Zakharov· 1 shared A. Venkatakrishnan· 1 shared A. Viraktamath· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

K. R. Brimacombe

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A deep learning framework for predicting the neutralizing activity of COVID-19 therapeutics and vaccines against evolving SARS-CoV-2 variants

R. P. Matson, I. Y. Comba, E. Silvert, M. J. Niesen, K. Murugadoss, D. Padwardhan, R. Suratekar, E.-G. Goel, B. J. Poelaert, K. Wan, K. R. Brimacombe, A. Venkatakrishnan, V. Soundararajan

This paper develops a deep learning model to predict neutralizing activity of COVID-19 therapeutics and vaccines against SARS-CoV-2 variants, finding reduced activity against newer variants like EG.5 and XBB.1.16.

bioRxiv · Oct 24, 2023 · PreprintImmunology

Real-time sharing of drug screening data on the NCATS OpenData Portal accelerates translational research

K. R. Brimacombe, P. C. Scully, T. Zhao, R. T. Eastman, X. Hu, K. Wang, M. Backus, B. Baljinnyam, C. Z. Chen, L. Chen, Y. Cheng, D. P. Davis, K. Duerr, T. Eicher, A. Friedman, , M. D. Hall

This paper describes the NCATS OpenData Portal, a platform for real-time sharing of drug screening data that accelerates translational research by enabling immediate access to large-scale datasets.

bioRxiv · Jun 4, 2020 · PreprintBiochemistry